Literature DB >> 19020752

Establishment of a novel neuroblastoma mouse model.

Hiroshi Iwakura1, Hiroyuki Ariyasu, Naotetsu Kanamoto, Kiminori Hosoda, Kazuwa Nakao, Kenji Kangawa, Takashi Akamizu.   

Abstract

Neuroblastoma is the most common childhood cancer, which arises from sympathetic neural precursors. Because the prognosis of advanced neuroblastoma is known to be poor, developments of new anti-cancer drugs are desperately needed. For screening of therapeutic drugs for neuroblastoma, genetically engineered animal models would be useful. In an attempt to obtain transgenic mice carrying simian virus 40 T-antigen gene under control of tetracycline responsive elements with cytomegalovirus promoter, we found one line of mice exhibiting bilateral adrenal tumors by leakage expression of T-antigen in adrenal gland. These adrenal tumors contained small round tumor cells with increased N/C ratio, showing chromogranin A and neuron specific enolase-like immunoreactivity. By electron microscopy, tumor cells containing neuritic processes with synaptic vesicles surrounding them were observed. The plasma levels of dopamine were significantly elevated in these transgenic mice. MYCN expression levels were significantly elevated in these tumors. These findings indicated that the adrenal tumor was a neuroblastoma. This mouse model would be a useful tool for development of chemotherapeutic drugs and understanding the etiology of neuroblastoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19020752

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  8 in total

Review 1.  Genetically engineered murine models--contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastoma.

Authors:  Louis Chesler; William A Weiss
Journal:  Semin Cancer Biol       Date:  2011-09-21       Impact factor: 15.707

2.  Adrenal tumor volume in a genetically engineered mouse model of neuroblastoma determined by magnetic resonance imaging.

Authors:  Kumi Kawano; Yoshiyuki Hattori; Hiroshi Iwakura; Takashi Akamizu; Yoshie Maitani
Journal:  Exp Ther Med       Date:  2012-05-02       Impact factor: 2.447

3.  Tumor-associated macrophages promote neuroblastoma via STAT3 phosphorylation and up-regulation of c-MYC.

Authors:  Michael D Hadjidaniel; Sakunthala Muthugounder; Long T Hung; Michael A Sheard; Soheila Shirinbak; Randall Y Chan; Rie Nakata; Lucia Borriello; Jemily Malvar; Rebekah J Kennedy; Hiroshi Iwakura; Takashi Akamizu; Richard Sposto; Hiroyuki Shimada; Yves A DeClerck; Shahab Asgharzadeh
Journal:  Oncotarget       Date:  2017-09-16

Review 4.  The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII.

Authors:  Antonietta Rosella Farina; Lucia Cappabianca; Pierdomenico Ruggeri; Luciana Gneo; Cristina Pellegrini; Maria-Concetta Fargnoli; Andrew Reay Mackay
Journal:  J Exp Clin Cancer Res       Date:  2018-06-18

5.  Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastoma.

Authors:  Soheila Shirinbak; Randall Y Chan; Shilpa Shahani; Sakunthala Muthugounder; Rebekah Kennedy; Long T Hung; G Esteban Fernandez; Michael D Hadjidaniel; Babak Moghimi; Michael A Sheard; Alan L Epstein; Muller Fabbri; Hiroyuki Shimada; Shahab Asgharzadeh
Journal:  Oncoimmunology       Date:  2021-01-04       Impact factor: 8.110

6.  A Nanoradiomics Approach for Differentiation of Tumors Based on Tumor-Associated Macrophage Burden.

Authors:  Zbigniew Starosolski; Amy N Courtney; Mayank Srivastava; Linjie Guo; Igor Stupin; Leonid S Metelitsa; Ananth Annapragada; Ketan B Ghaghada
Journal:  Contrast Media Mol Imaging       Date:  2021-06-14       Impact factor: 3.161

7.  Combination therapy with gefitinib and doxorubicin inhibits tumor growth in transgenic mice with adrenal neuroblastoma.

Authors:  Kumi Kawano; Yoshiyuki Hattori; Hiroshi Iwakura; Takashi Akamizu; Yoshie Maitani
Journal:  Cancer Med       Date:  2013-04-02       Impact factor: 4.452

Review 8.  Zebrafish as a Neuroblastoma Model: Progress Made, Promise for the Future.

Authors:  Shuai Li; Kok Siong Yeo; Taylor M Levee; Cassie J Howe; Zuag Paj Her; Shizhen Zhu
Journal:  Cells       Date:  2021-03-06       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.